In our cells, mitochondria determine life and death, and thus the health and disease of the organism.
Therefore, the protection and activation of mitochondria are the focus of my prevention and therapy efforts.
Origin & Mission
From the school of the founders of modern cellular medicine
Dr. Franz Enzmann is a student of Prof. Karl Folkers, the
discoverer of ubiquinone Q10, and Prof. Rolf Luft, the father
of mitochondrial medicine. Since 1967, he has tirelessly
dedicated himself to advancing the use of coenzyme Q10
in prevention and therapy.
Therefore, the protection and activation of mitochondria
is the focus of his every preventive and
therapeutic application.
Prof. Karl Folkers
Discoverer of Ubiquinone Q10 – Teacher & Pioneer
Prof. Rolf Luft
Father of mitochondrial medicine and discoverer of the first acquired mitochondriopathy
Career path
Six decades of research
From natural product chemistry and the structural elucidation of the first hypothalamic hormone to mitochondrial medicine.
Studies & PhD in Natural Product Chemistry
- Diploma, University of Erlangen
- Doctorate on the subject of “Electron Burning” (the mass spectrometer in a test tube) under Prof. Schildknecht, University of Heidelberg
Research on Q10 and the hypothalamus hormone, USA
- McBean Fellow with Prof. Folkers, Stanford Research Institute, USA; first use of Q10 in children
- Research associate with Prof. Folkers, University of Texas, USA; hypothalamic regulatory hormones
- Structural elucidation of the first hypothalamic hormone (TRH) as a prerequisite for the Nobel Prize in Medicine for Prof. Schally (1977)
Hoechst AG – Insulin/Endocrinology Division
- Medical Department, Hoechst AG: worldwide responsibility for the clinical development of drug candidates for diabetes, lipid metabolism disorders, and neuroendocrinology; potential applications of coenzyme Q10
- Co-development and launch of the first genetically engineered human insulin, Eli Lilly
Byk Guilden, Research and Development
- Managing Director Research & Development, Byk Gulden, Constance
- Establishment of molecular biology with the goal of producing lung surfactant
Bissendorf Peptide, Peptide Research
- Managing Director Peptide Research, Bissendorf Peptide
Boehringer, SERVA Electrophoresis
- Managing Director SERVA Feinbiochemica, Boehringer Ingelheim
- Reconstruction of diagnostics
Founding of mse Pharmazeutika GmbH
- Founding of mse Pharmazeutika GmbH together with Ms. Uta in Bad Homburg v. d. H.
Founding of IMMA
- Foundation of the International Mitochondrial Medicine Association (IMMA)
The Nobel Prize Duel
At the Baylor College of Medicine in Houston (Texas), the two scientists Schally and Guillemin began a joint search in the 1950s for hormones produced by the hypothalamus. Later, however, they became research rivals and competed for the Nobel Prize.
In 1969, Dr. [Name] together with Prof. Folkers finally determined the structure of the first hypothalamic hormone (TRH) within just five months. This was the prerequisite for the Nobel Prize in Medicine, which Prof. Schally and Prof. Guillemin jointly received in 1977.
Memberships
- Founder of the International Mitochondrial Medicine Association (IMMA)
- Founding member of the International Coenzyme Q10 Association
- Member of the German Diabetes Society (DDG)
- Member of the German Society of Endocrinology (DGE)
- Member of the German Parkinson Society (DPG)
- Member of the German PSP Society
- Member of the Society for Bioimmunotherapy and
Micronutrition (GBIT)
Awards
1969
Van Meter Prize
American Thyroid Association
2016
IHK Award "Excellent Technology Transfer"
“Innovative alternative methods for product testing using the example of QuinoMit” in cooperation with Prof. Dr. J. Bergemann (HAW Albstadt-Sigmaringen)
Articles & Studies
View all-
Publication
Chronic fatigue syndrome
CFS: Patients suffer from permanent physical and mental exhaustion of unknown origin, which cannot be improved, or only slightly improved, by rest periods. Doctors define CFS as chronic fatigue when...
read moreChronic fatigue syndrome
CFS: Patients suffer from permanent physical and mental exhaustion of unknown origin, which cannot be improved, or only slightly improved, by rest periods. Doctors define CFS as chronic fatigue when...
read more -
Patient information
Autism and ADHD
The manifestations of attention deficit hyperactivity disorder (ADHD) and autism are different expressions of the same underlying disorders. Both are developmental disorders that begin in childhood.
read moreAutism and ADHD
The manifestations of attention deficit hyperactivity disorder (ADHD) and autism are different expressions of the same underlying disorders. Both are developmental disorders that begin in childhood.
read more
